Kprx stock price.

Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.R$476.67B. Suncor Energy Inc. -0.47%. $57.67B. XOM | Complete Exxon Mobil Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.1.75%. $126.63B. Citigroup Inc. 2.45%. $90.39B. PYPL | Complete PayPal Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.S&P BSE SENSEX - India's Index the World Tracks. Get live S&P BSE SENSEX quotes. S&P BSE Sensex Heat Map a great tool to track S&P BSE SENSEX stocks. Gainers, losers, volume toppers in S&P BSE SENSEX Stocks. Corporate announcements of S&P BSE SENSEX stocks, Share Market Today | Share Market Live updates. Share Market …The Kiora Pharmaceuticals Inc (KPRX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $28.38, representing a +5,060% increase from the current price of $0.55. The highest analyst price target is $35.44, and the lowest is $21.32.

Zacks Market Edge Highlights: Canopy Growth, Tilray Brands, Constellation Brands, Innovative Industrial Properties and Jazz Pharmaceuticals. 11/24/23-8:00AM EST Zacks. 11/22/23-1:15PM EST Zacks ...The Kiora Pharmaceuticals, Inc. stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of KPRX stock is predicted to rise by 0.82% tomorrow and lose -1.08% in the next 7 days.

KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

Who Owns Kiora Pharmaceuticals, Inc. (KPRX) Kiora Pharmaceuticals, Inc. (KPRX) is a publicly traded company, meaning that its ownership is spread across a large number of shareholders who own the company's stock. The largest shareholders of Kiora Pharmaceuticals, Inc. are institutional investors, such as mutual funds, pension funds, …View the latest AT&T Inc. (T) stock price, news, historical charts, analyst ratings and financial information from WSJ.Barron's MarketWatch IBD DJIA Futures 35667 0.50% U.S. 10 Yr -3/32 Yield 4.301% Euro 1.0916 0.49% Subscribe Sign In Kiora Pharmaceuticals Inc. KPRX (U.S.: Nasdaq) …Aug 25, 2022 · It looks like we have retail traders on social media to thank for KPRX stock rising in price today. Investors on Twitter (NYSE: TWTR ) are hyping up shares of the company’s stock today in what ... Forecast Price target 12.83 0.00 0.00% The 3 analysts offering 1 year price forecasts for KPRX have a max estimate of — and a min estimate of —. Analyst rating Based on 3 …

NVIDIA Corporation Common Stock. $452.12 -0.61 -0.13%. Kiora Pharmaceuticals, Inc. Common Stock (KPRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US ...

View the full Dow Jones Industrial Average (DJIA) index overview including the latest stock market news, data and trading information.

Find the latest FREYR Battery (FREY) stock quote, history, news and other vital information to help you with your stock trading and investing.KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of ophthalmic diseases. Its pipeline consists of three product candidates, including KIO-101, KIO-301, and KIO-201. Its lead product, KIO-301, is a potential vision-restoring small molecule ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.$176.65 UNCH TSLA Tesla, Inc. Common Stock $220.20 +0.24 +0.11% NVDA NVIDIA Corporation Common Stock $450.47 +0.42 +0.09% MSFT Microsoft Corporation Common Stock $352.60 -0.20 -0.06%...

Get the latest KPRX (KPRX) stock quote, charts, news and other financial information to help you make more informed trading and investment decisions. KPRX is a …Nov 27, 2023 · Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for KPRX stock stock is $41.5, which predicts an increase of 7,117.39%. The lowest target is $2.00 and the highest is $119. On average, analysts rate KPRX stock stock as a strong buy. Nov 24, 2023 · The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... Nov 20, 2023 ... So, for instance, a stock could have a price-to-book ranking in the ... KPRX, Industry Median. Price/Sales, na, na, 2.32. Price/Earnings, na, na ...In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Kiora Pharmaceuticals (KPRX - Research Report), with a price target of $2.00. The company's shares closed yesterday at $0.63.According to TipRanks, Chen is an analyst with an average return of -29.9% and a 23.72% success rate.Dec 1, 2023 · Kiora Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.740 per share for the current fiscal year. Kiora Pharmaceuticals Inc does not currently pay a dividend. According to 3 stock analysts, the average 12-month stock price forecast for KPRX stock stock is $41.5, which predicts an increase of 7,459.20%. The lowest target is $2.00 and the highest is $119. On average, analysts rate KPRX stock stock as a strong buy.

KPRX Kiora Pharmaceuticals, Inc. Stock Price & Overview 4.03K followers $0.56 -0.0001 ( -0.02%) 2:35 PM 11/21/23 NASDAQ | $USD | Post-Market: $0.57 +0.01 …

With Kiora Pharmaceuticals stock trading at $0.53 per share, the total value of Kiora Pharmaceuticals stock (market capitalization) is $4.07M. Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015.Track Catalyst Pharmaceuticals Inc (CPRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFind the latest Eos Energy Enterprises, Inc. (EOSE) stock quote, history, news and other vital information to help you with your stock trading and investing.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Mar 1, 2022 ... One thing to consider is that the analyst outlook remains optimistic with the current pipeline. Maxim Group initiated coverage on KPRX stock ...The value each KPRX share was expected to gain vs. the value that each KPRX share actually gained. Kiora Pharmaceuticals ( KPRX) reported Q3 2023 earnings per share (EPS) of -$0.89, missing estimates of -$0.52 by 70.31%. In the same quarter last year, Kiora Pharmaceuticals 's earnings per share (EPS) was -$6.03.The Catalyst Pharmaceuticals stock price gained 2.70% on the last trading day (Friday, 1st Dec 2023), rising from $14.43 to $14.82. During the last trading day the stock fluctuated 3.48% from a day low at $14.35 to a day high of $14.85. The price has risen in 8 of the last 10 days and is up by 10.76% over the past 2 weeks.5 analysts have issued 1-year price objectives for Aravive's shares. Their ARAV share price targets range from $9.00 to $18.00. On average, they anticipate the company's stock price to reach $12.25 in the next year. This suggests a possible upside of 8,907.4% from the stock's current price.Jun 2, 2023 · Encinitas, California-- (Newsfile Corp. - June 2, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the pricing of an underwritten public offering for ... Find the latest Cognizant Technology Solutions Corporation (CTSH) stock quote, history, news and other vital information to help you with your stock trading and investing.

View Cassava Sciences (SAVA) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo ... (KPRX) and Bluebird Bio (BLUE).

Nov 30, 2023 · A high-level overview of Kiora Pharmaceuticals, Inc. (KPRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Kiora Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.740 per share for the current fiscal year. Kiora Pharmaceuticals Inc does not currently pay a dividend.Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...With Kiora Pharmaceuticals stock trading at $0.53 per share, the total value of Kiora Pharmaceuticals stock (market capitalization) is $4.07M. Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015.Kiora ended the quarter with $5.4 million in cash and cash equivalents and $1.3 million in tax receivables. Shares +2.34% in after-hours trading after the report. Webull offers KIORA PHARMACEUTICALS INC (KPRX) historical stock prices, in-depth market analysis, NASDAQ: KPRX real-time stock quote data, in-depth charts.Barron's MarketWatch IBD DJIA Futures 35667 0.50% U.S. 10 Yr -3/32 Yield 4.301% Euro 1.0916 0.49% Subscribe Sign In Kiora Pharmaceuticals Inc. KPRX (U.S.: Nasdaq) …3 brokers have issued 1-year price targets for Kiora Pharmaceuticals' stock. Their KPRX share price targets range from $7.00 to $119.00. On average, they anticipate the company's stock price to reach $46.00 in the next year. This suggests a possible upside of 8,955.1% from the stock's current price. View analysts price targets for KPRX or view ...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.Current Trading Halts. Historical Trading Halts. News Pending/News Dissemination and Limit Up Limit Down (LULD) for the current day. Time displayed in Eastern Time (ET). Page display will auto-refresh for 30 mins after initial display. Download CSV. Halt Date. Halt Time.Kiora Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target KPRX. High $ 33.00: Median $ 3.50: Low $ 2.00: Average $ 12.83: Current ...1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest Rigetti Computing, Inc. (RGTI) stock quote, history, news and other vital information to help you with your stock trading and investing.Also Known As EyeGate Pharmaceuticals. Legal Name Kiora Pharmaceuticals, Inc. Stock Symbol NASDAQ:KPRX. Company Type For Profit. Contact Email [email protected]. Phone Number 7813983811. Kiora is a clinical-stage specialty pharmaceutical company developing and commercializing products for treating …

Nikola stock is moving on news of a share sale.; However, the company isn’t behind this latest stock offering. Instead, certain shareholders are reselling up to 10,266,209 shares of NKLA stock.Kiora Pharmaceuticals (KPRX) stock dropped 50% on Friday after the firm priced an underwritten public offering for gross proceeds of ~$5.5M.The offering is comprised of ~1.4M shares,...Based on short-term price targets offered by three analysts, the average price target for Kiora Pharmaceuticals, Inc. comes to $12.33. The forecasts range from a low of $2.00 to a high of $33.00 ...Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision. Learn more about our companyInstagram:https://instagram. uipath stock forecastbest insurance for musical instrumentshighest yield reitcustom truck one source stock KPRX’s Market Performance. The stock of Kiora Pharmaceuticals Inc (KPRX) has seen a 11.98% increase in the past week, with a 9.98% rise in the past month, and a 19.87% gain in the past quarter. The volatility ratio for the week is 4.03%, and the volatility levels for the past 30 days are at 5.80% for KPRX. The simple moving average for the ...Webull offers KIORA PHARMACEUTICALS INC (KPRX) historical stock prices, in-depth market analysis, NASDAQ: KPRX real-time stock quote data, in-depth charts. top 100 investment companies in usaold us quarter dollar Feb 10, 2023 ... ... price targets on the company's stock and three raising them. ... Kiora Pharmaceuticals (KPRX) shares zoomed 109% this week from $3.28 on Monday ... real estate etf stock With Kiora Pharmaceuticals stock trading at $0.53 per share, the total value of Kiora Pharmaceuticals stock (market capitalization) is $4.07M. Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015.On August 1, 2022, the stock started to rise incredibly fast and, despite the lack of a catalyst, surged from its IPO price to $721.23, a 21,000% increase, resulting in a market capitalization of over $310 billion. It put AMTD Digital's market capitalization higher than companies like Bank of America, Coca-Cola, Shell and Costco.